Direct heteroduplex analysis and a universal heteroduplex generator assay were performed to detect rifampin resistance rapidly in Turkish Mycobacterium tuberculosis isolates. Cross-resistance to rifapentine, rifabutin, and rifalazil was investigated. A relationship between specific mutations and resistance patterns, which can guide the choice of an appropriate therapeutic regimen for tuberculosis patients, was identified.
Rifampin is a key component of short-course multidrug antituberculosis therapy. It binds to the ␤ subunit of the DNAdependent RNA polymerase encoded by the gene rpoB and therefore inhibits transcription (7, 8) . Ninety-six percent of rifampin-resistant isolates have missense mutations, deletions, or insertions in the 81-bp rifampin resistance-determining region of the rpoB gene coding for amino acids 507 through 533. Codons 531, 526, and 516 are reported as the most frequent mutation sites, with codon 531 mutations being the most common (7) .
The emergence of rifampin-resistant strains has led to the use of structural analogs of rifampin. Rifapentine, rifabutin, and rifalazil are new rifamycin derivatives and are tested in rifampin-resistant isolates. Recently, several studies showed a correlation between specific mutations in rpoB and the level of resistance to rifamycin derivatives (6, 11, 14) .
In this study we amplified the resistance-determining region of the rpoB gene by PCR and performed direct heteroduplex analysis (1, 15) and a universal heteroduplex generator (UHG) assay (13) for rapid detection of rifampin resistance in clinical isolates of Mycobacterium tuberculosis. We performed DNA sequencing for certain isolates and determined the rifamycin cross-resistance in rifampin-resistant isolates and showed the correlation between antimycobacterial activities of rifamycins and mutations in the rpoB gene.
Ninety-seven rifampin-resistant and 21 rifampin-susceptible isolates of M. tuberculosis were included in this study. All isolates were isolated from different patients in the microbiology laboratory of Atatürk Chest Diseases and Chest Surgery Center, Ankara, Turkey. The rifampin-susceptible strain ATCC 25177 H37Ra was used as a negative control.
Susceptibility testing was performed by the proportion method (2, 3, 4) with Middlebrook 7H10 agar. Each drug (rifampin, rifapentine, rifabutin, and rifalazil) was added at a concentration of 1 g/ml. Isolates with growth on drug-containing media that was Ͼ1% greater than growth on control media were considered resistant.
DNA extracts from clinical isolates and from the rifampinsusceptible control strain H37Ra of M. tuberculosis, already grown on Löwenstein-Jensen media, were prepared by the boiling method as described previously (5) .
A 305-bp region of the rpoB gene covering the 81-bp rifampin resistance-determining region was amplified by using TbRif-1 and TbRif-2 primers, and DNA duplexes were obtained as previously described by Willams et al. (9) . They were loaded on a 20-cm-long 1ϫ mutation detection enhancement (FMC Bioproducts) gel containing 15% urea. The electrophoresis was run at 300 V for 24 h with 1ϫ Tris-boric acid-EDTA buffer.
The UHG was a gift from Diana Williams, Hansen's Disease Research Laboratory, Louisiana State University. The heteroduplex generator is a synthetic (Genelab) PCR-amplified (double-stranded) 181-bp DNA fragment. It mimics the genomic DNA and covers the 81-bp rifampin resistance-determining region. It has four 3-bp deletions and three 2-bp substitutions (10) . We performed the UHG assay by using primers rpo105 and rpo273 and the protocol described by Williams et al. (10, 12) .
We performed DNA sequencing for 14 strains showing different drug susceptibility and heteroduplex patterns. The PCR products were separated from unincorporated nucleic acids and primers with PCR Preps DNA purification system (Promega) according to the manufacturer's instructions. DNA-sequencing reactions were performed with a DNA sequencing kit (Silver Sequence DNA sequencing system; Promega). Primers TbRif-1 and TbRif-2 and a new primer, TbRif-0 (5Ј AAC CGA CGA CAT CGA CCA CT 3Ј), designed to show frequent mutation sites more clearly, were used for PCR and DNAsequencing reactions.
Fifty-one of 97 (52.6%) rifampin-resistant isolates were resistant to all four rifamycin derivatives tested. Thirty-five (36%) isolates were resistant to rifampin and rifapentine, and nine (9.3%) isolates were resistant to rifampin only (Table 1 ). All rifampin-susceptible strains were susceptible to other rifamycin derivatives.
Among 97 rifampin-resistant isolates, 90 were classified as resistant to rifampin by direct heteroduplex analysis. All 21 rifampin-susceptible isolates were classified as susceptible to rifampin by direct heteroduplex analysis. The sensitivity and specificity of direct heteroduplex analysis, compared to the sensitivity and specificity of conventional drug susceptibility testing, were 92.7 and 100%, respectively. The proportion of agreement was 94%.
M. tuberculosis H37Ra and rifampin-susceptible isolates were expected to form a single band belonging to homoduplex DNA, and resistant isolates were expected to form extra bands due to heteroduplex DNA with mismatches moving at different speeds than the homoduplex DNA in electrophoresis (Fig. 1) .
The UHG assay detected 88 of 97 rifampin-resistant strains. All 21 rifampin-susceptible isolates produced the electrophoretic patterns expected from susceptible strains with the UHG assay. The sensitivity and specificity of this method, compared to those of the proportion plate method, were 90.7 and 100%, respectively. The proportion of agreement was 92.4%. A comparison of the two heteroduplex analysis methods is shown in Table 2 . The difference in detection of rifampinresistant isolates by the two methods wasn't statistically significant (P ϭ 0.791). Among 14 resistant isolates, seven different mutations were identified (Table 3 ). All were single nucleotide mutations involving codons 531, 526, 516, and 513, which constitute the sites where mutations are most frequently encountered. While the isolates with mutations in codons 531 and 513 were resistant to all four rifamycin derivatives; the isolates with mutations in codon 516 were resistant to rifampin and rifapentine but susceptible to rifabutin and rifalazil. The isolates with mutations in codon 526 were resistant to either two or four rifamycin derivatives depending on the amino acid change. The isolates with glutamic acid and leucine substitutions were resistant to rifampin and rifapentine but susceptible to rifabutin and rifalazil. Tyrosine substitutions created resistance to all four rifamycin derivatives.
In this study, 46% of rifampin-resistant isolates were susceptible to rifabutin, which is available on the market and may be an important alternative to rifampin.
In conclusion, both heteroduplex methods can be used for rapid diagnosis of rifampin resistance, because their sensitivity and specificity are high. Detection of specific mutations in the rpoB gene by DNA sequencing may be very useful for deter- 
